- Home
- / Kartos Therapeutics
Kartos Therapeutics
Kartos Therapeutics Summary
Company Summary
- Overview
- Kartos Therapeutics is a clinical-stage biopharmaceutical company. It develops MDM2 inhibitors and therapies for cancer patients.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Redwood City, CA, US | view all locations
- Website
- https://www.kartosthera.com
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Beth Mechling, COO
Greg Slatter, SVP, Clinical Pharmacology
Scott Sandler, SVP, Finance
LocationsView all
1 location detected
Redwood City, CA HQ
United States
275 Shoreline Drive, Suite 300